Volver al feed
GeneralArs Technica - All contentBeth Mole

Contenido en inglés

US-backed vaccine trial on babies canceled after international outcry

US-backed vaccine trial on babies canceled after international outcry

En resumen

Government officials in Guinea-Bissau have formally rejected a clinical trial that would be run by Danish researchers and funded by the US to look for alleged nonspecific harms from the newborn dose of the hepatitis B vaccine. The vaccine dose is currently recommended globally for all newborns and has been used safely

Fuente primaria
— Leer artículo original
Publicado
Tema
General

Government officials in Guinea-Bissau have formally rejected a clinical trial that would be run by Danish researchers and funded by the US to look for alleged nonspecific harms from the newborn dose of the hepatitis B vaccine.

The vaccine dose is currently recommended globally for all newborns and has been used safely and effectively for decades.

In an email to Ars Technica, one of the trial's lead researchers, Christine Stabell Benn of Bandim Health Project and the University of Southern Denmark, said that Guinea-Bissau's Council of Ministers "formally reaffirmed its non-acceptance of the study on 16 October." The revelation that the study was formally rejected last week comes after news on Monday that judicial police in Guinea-Bissau raided Bandim Health's offices and seized vaccines .

Stabell Benn highlighted that the police search came after the trial was rejected. Read full article Comments

Este resumen proviene de Ars Technica - All content. Lee el artículo completo en la fuente original.

Leer artículo original — Ars Technica - All content

Referencias

Más en General